MIDOL COMPLETE
- Product NDC
- 70264-012
- 11-digit product format
- 702640012
- Labeler code
- 70264
- Product ID
- 70264-012_43c8728c-3666-eb53-e063-6294a90af230
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- acetaminophen, caffeine, and pyrilamine maleate
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- R J General Corporation
- Application
- M013
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2014-02-10
- Substance
- PYRILAMINE MALEATE; ACETAMINOPHEN; CAFFEINE
- Active strength
- 15; 500; 60 mg/1; mg/1; mg/1
- Pharmacologic classes
- Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2022-08-30 03:57 UTC · source 2022-08-29 | excluded product | product | fb8cb913e6d1… | eb8c232b6be0… | |
| 2022-08-30 03:57 UTC · source 2022-08-29 | excluded package | package | 70264-012-01 | fb8cb913e6d1… | eb8c232b6be0… |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded product | product | 86f5da6cb304… | a595104c45d7… | |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded package | package | 70264-012-01 | 86f5da6cb304… | a595104c45d7… |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded product | product | bd6a592717d7… | 303034d00443… | |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded package | package | 70264-012-01 | bd6a592717d7… | 303034d00443… |
| 2021-12-27 23:28 UTC · source 2021-12-27 | excluded product | product | 8dfbde2a14a4… | c9ff85d89658… | |
| 2021-12-27 23:28 UTC · source 2021-12-27 | excluded package | package | 70264-012-01 | 8dfbde2a14a4… | c9ff85d89658… |
| 2020-12-18 03:04 UTC · source 2020-12-17 | excluded product | product | e2bbac7714bc… | 27bdfed8d636… | |
| 2020-12-18 03:04 UTC · source 2020-12-17 | excluded package | package | 70264-012-01 | e2bbac7714bc… | 27bdfed8d636… |
| 2020-06-10 20:45 UTC · source 2020-06-10 | excluded product | product | 9bebd1f3094a… | 5416666fcb17… | |
| 2020-06-10 20:45 UTC · source 2020-06-10 | excluded package | package | 70264-012-01 | 9bebd1f3094a… | 5416666fcb17… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- MIDOL COMPLETE
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| PYRILAMINE MALEATE | 15 mg/1 |
| ACETAMINOPHEN | 500 mg/1 |
| CAFFEINE | 60 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| R35D29L3ZA | Internal UNII lookup |
| 362O9ITL9D | Internal UNII lookup |
| 3G6A5W338E | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1597298 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 0c09a178-1a07-4079-b4a6-d1657cb8e714 | Available on FDA.report |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 70264-012-01 | 2022-12-26 | C162847 | 48780-1 | 9d75b9d0-bb1e-f424-e053-dadaa90a57ce | MIDOL ® COMPLETE |
| 70264-012-01 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-bb1e-f424-e053-dadaa90a57ce | MIDOL ® COMPLETE |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70264-012-01 | MIDOL COMPLETE | 50 in 1 CARTON | TABLET | 50 | 7 | |
| 70264-012-01 | MIDOL COMPLETE | 2 in 1 POUCH | TABLET | 2 | 7 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Pain Relief | ACETAMINOPHEN | CHAIN DRUG MARKETING ASSOCIATION, INC. | 1c083e29-8732-4ecd-ab4b-9038acbd0b9d | 2025-05-22 | Warnings | M013 |
| TYLENOL For Children Plus Adults | ACETAMINOPHEN | Kenvue Brands LLC | 5bb8ef99-a94b-49f9-89f9-cd1ce0a47a42 | 2025-05-21 | Warnings | M013 |
| Children Acetaminophen | ACETAMINOPHEN | AARNA USA INC. | 25bcb9d5-f388-4ae7-8037-970ffe8d17f0 | 2025-05-16 | Warnings | M013 |
| ACETAMINOPHEN | ACETAMINOPHEN | HF Acquisition Co LLC, DBA HealthFirst | 35478de8-50d0-5d0a-e063-6294a90a88ba | 2025-05-16 | Warnings | M013 |
| Extra Strength Acetaminophen | ACETAMINOPHEN | Preferred Pharmaceuticals Inc. | 95f4b628-6d35-4f6b-91f9-b2d117f8e821 | 2025-05-16 | Warnings | M013 |
| good neighbor pharmacy childrens pain and fever | ACETAMINOPHEN | Amerisource Bergen | 268a789b-8f31-4739-9777-523249cac326 | 2025-05-13 | Warnings | M013 |
| ASPIRIN LOW DOSE | ASPIRIN LOW DOSE | AARNA USA INC. | 347edc8f-6391-b75e-e063-6394a90a1cf5 | 2025-05-06 | Warnings | M013 |
| Good Neighbor Pharmacy Infants Pain and Fever | ACETAMINOPHEN | Amerisource Bergen | 2cfbb8ad-3ecb-432b-9eb4-16c51bf23bb2 | 2025-05-06 | Warnings | M013 |
| ACETAMINOPHEN | ACETAMINOPHEN | AARNA USA INC. | 34157f6a-3031-4388-e063-6394a90a670f | 2025-05-01 | Warnings | M013 |
| ASPIRIN | ASPIRIN | HF Acquisition Co LLC, DBA HealthFirst | 2553d0cb-3f5c-7ea0-e063-6294a90a3cd4 | 2025-05-01 | Warnings, Adverse reactions | M013 |
| Aspirin 81mg Enteric Coated | ASPIRIN | Advanced Rx LLC | 606067bb-b07f-444e-9465-d1e187735f3a | 2025-05-01 | Warnings | M013 |
| ACETAMINOPHEN | ACETAMINOPHEN | AARNA USA INC. | 33f0e822-28af-9bb2-e063-6294a90a5175 | 2025-04-29 | Warnings | M013 |
| Extra Strength Acetaminophen | ACETAMINOPHEN | Geri-Care Pharmaceutical Corp | 27fcca07-f845-77fe-e063-6394a90aa2f8 | 2025-04-24 | Warnings | M013 |
| acetaminophen | ACETAMINOPHEN | A-S Medication Solutions | 46a6bbb9-ccd1-47a8-9e58-485f71f57063 | 2025-04-24 | Warnings | M013 |
| Acetaminophen | ACETAMINOPHEN | A-S Medication Solutions | 061c91d5-5aa8-4556-a344-197b7e8a10b8 | 2025-04-24 | Warnings | M013 |
| Acetaminophen | ACETAMINOPHEN | A-S Medication Solutions | c4f0f591-8501-4c6d-bf8e-ca3068ff65b5 | 2025-04-24 | Warnings | M013 |
| Extra Strength No-Pain | ACETAMINOPHEN | Safrel Pharmaceuticals, LLC. | 873f01dd-0701-5fd3-e053-2a95a90a6463 | 2025-04-23 | Warnings | M013 |
| Pain Reliever | ACETAMINOPHEN | Chain Drug Consortium | 60d4b392-6ed0-4115-8154-24eaf72504a5 | 2025-04-16 | Warnings | M013 |
| Premsyn pms Premenstrual Pain Relief | ACETAMINOPHEN AND PAMABROM AND PYRILAMINE MALEATE | Focus Consumer Healthcare, LLC | 5b6f6260-69ae-cfeb-e053-2a91aa0a6b49 | 2025-04-14 | Warnings | M013 |
| BackAid Max | ACETAMINOPHEN, PAMABROM | Kobayashi Healthcare International, Inc. | fb9a5647-b7c9-4820-b148-91060e34cb83 | 2025-04-14 | Warnings | M013 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1597298 | acetaminophen 500 MG / caffeine 60 MG / pyrilamine maleate 15 MG Oral Tablet | PSN | 0c09a178-1a07-4079-b4a6-d1657cb8e714 | 7 |
| 1597298 | acetaminophen 500 MG / caffeine 60 MG / pyrilamine maleate 15 MG Oral Tablet | SCD | 0c09a178-1a07-4079-b4a6-d1657cb8e714 | 7 |
| 1597298 | APAP 500 MG / Caffeine 60 MG / Pyrilamine Maleate 15 MG Oral Tablet | SY | 0c09a178-1a07-4079-b4a6-d1657cb8e714 | 7 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 70264-012-01 | 70264001201 | 50 POUCH in 1 CARTON (70264-012-01) / 2 TABLET in 1 POUCH | 50 pouch | 2014-10-02 | 0000-00-00 | No | No | Current |